BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21169409)

  • 1. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
    Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
    Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
    Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
    Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling.
    Wu MJ; Jan CI; Tsay YG; Yu YH; Huang CY; Lin SC; Liu CJ; Chen YS; Lo JF; Yu CC
    Mol Cancer; 2010 Oct; 9():283. PubMed ID: 20979610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.
    Rasanen K; Sriswasdi S; Valiga A; Tang HY; Zhang G; Perego M; Somasundaram R; Li L; Speicher K; Klein-Szanto AJ; Basu D; Rustgi AK; Speicher DW; Herlyn M
    Mol Cell Proteomics; 2013 Dec; 12(12):3778-92. PubMed ID: 24037664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct subpopulations of head and neck cancer cells with different levels of intracellular reactive oxygen species exhibit diverse stemness, proliferation, and chemosensitivity.
    Chang CW; Chen YS; Chou SH; Han CL; Chen YJ; Yang CC; Huang CY; Lo JF
    Cancer Res; 2014 Nov; 74(21):6291-305. PubMed ID: 25217518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.
    Muhammad N; Bhattacharya S; Steele R; Phillips N; Ray RB
    Clin Cancer Res; 2017 Jun; 23(12):3120-3128. PubMed ID: 27965308
    [No Abstract]   [Full Text] [Related]  

  • 8. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
    Zhang K; Zhang M; Zhao H; Yan B; Zhang D; Liang J
    Dis Esophagus; 2012; 25(8):731-9. PubMed ID: 22458600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anterior gradient protein 2 expression in high grade head and neck squamous cell carcinoma correlated with cancer stem cell and epithelial mesenchymal transition.
    Ma SR; Wang WM; Huang CF; Zhang WF; Sun ZJ
    Oncotarget; 2015 Apr; 6(11):8807-21. PubMed ID: 25871396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
    Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
    Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinoma.
    Bae WJ; Koo BS; Lee SH; Kim JM; Rho YS; Lim JY; Moon JH; Cho JH; Lim YC
    Br J Cancer; 2017 Dec; 117(12):1810-1818. PubMed ID: 29096401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel C-Terminal Heat Shock Protein 90 Inhibitors (KU711 and Ku757) Are Effective in Targeting Head and Neck Squamous Cell Carcinoma Cancer Stem cells.
    Subramanian C; Kovatch KJ; Sim MW; Wang G; Prince ME; Carey TE; Davis R; Blagg BSJ; Cohen MS
    Neoplasia; 2017 Dec; 19(12):1003-1011. PubMed ID: 29121598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of S100A4 and endoglin is associated with metastatic disease in head and neck squamous cell carcinoma.
    Oliveira MV; Fraga CA; Barros LO; Pereira CS; Santos SH; Basile JR; Gomez RS; Guimarães AL; De-Paula AM
    Clin Exp Metastasis; 2014 Aug; 31(6):639-49. PubMed ID: 24798676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
    Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
    Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
    Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
    Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of microRNA-494-targeting Bmi1 and ADAM10 by silibinin ablates cancer stemness and predicts favourable prognostic value in head and neck squamous cell carcinomas.
    Chang YC; Jan CI; Peng CY; Lai YC; Hu FW; Yu CC
    Oncotarget; 2015 Sep; 6(27):24002-16. PubMed ID: 26090866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p70S6K promotes IL-6-induced epithelial-mesenchymal transition and metastasis of head and neck squamous cell carcinoma.
    Wu D; Cheng J; Sun G; Wu S; Li M; Gao Z; Zhai S; Li P; Su D; Wang X
    Oncotarget; 2016 Jun; 7(24):36539-36550. PubMed ID: 27174914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.
    Moon JH; Lee SH; Koo BS; Kim JM; Huang S; Cho JH; Eun YG; Shin HA; Lim YC
    Oral Oncol; 2020 Dec; 111():104948. PubMed ID: 32771963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.